Servier, an independent international pharmaceutical group focusing on oncology, neurology and cardio-metabolic diseases, welcomes this public consultation. Our unique governance as an independent company governed by a non-profit Foundation allows us to maintain a long-term vision focused solely on therapeutic progress and patient needs.
Servier
Company · France · EU Transparency Register 18370091485-91
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #853 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- Servier is a member of EFPIA (European Federation of Pharmaceutical Industries and Associations), of the GIRP (the Eu…
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Head office
- Suresnes, France
- EU office
- Anderlecht
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Servier in PolicySpeak: request access →
Work at Servier? so we know who speaks for it.
Their record over time
Servier filed 1 position on 27 Jul 2026, across 1 of the 326 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Servier’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.